News & events

2019 ASM Biothreats

The Latham BioPharm Group (LBG) will be attending the 2019 ASM Biothreats meeting. The focus of this meeting will be what’s new in high consequence pathogen research, biological threat reduction, product development and policy. Experts in academia, industry and government present and discuss the latest developments in this emerging field. 

Please reach out to LBG to schedule some time to learn about how LBG can support your biodefense efforts.